thalidomide has been researched along with mln 8237 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dickinson, M; Prince, HM | 1 |
1 review(s) available for thalidomide and mln 8237
| Article | Year |
|---|---|
Emerging drugs for T-cell lymphoma.
Topics: Alemtuzumab; Anaplastic Lymphoma Kinase; Antibodies, Monoclonal, Humanized; Azepines; Brentuximab Vedotin; Histone Deacetylase Inhibitors; Humans; Immunoconjugates; Lenalidomide; Lymphoma, T-Cell; Pyrimidines; Receptor Protein-Tyrosine Kinases; Thalidomide | 2014 |